Literature DB >> 10683338

A role for bovine herpesvirus 1 (BHV-1) glycoprotein E (gE) tyrosine phosphorylation in replication of BHV-1 wild-type virus but not BHV-1 gE deletion mutant virus.

A M Shaw1, L Braun, T Frew, D J Hurley, R R Rowland, C C Chase.   

Abstract

Bovine herpesvirus 1 (BHV-1), an alphaherpesvirus, is a major pathogen that causes respiratory and reproductive infections. We observed tyrosine phosphorylation of a 95-kDa viral protein and dephosphorylation of 55- and 103-kDa cellular proteins during the course of BHV-1 infection. We demonstrated BHV-1 glycoprotein E (gE) to be the tyrosine phosphorylated viral protein by immunoprecipitation. Inhibition of phosphorylation of BHV-1 gE by tyrosine kinase inhibitors genistein and tyrphostin AG1478 substantially lowered the viral titer in Madin-Darby bovine kidney cells. The decrease in viral titer was directly proportional to the decrease in phosphorylation of the BHV-1 gE. Interestingly, these kinase inhibitors did not inhibit the replication of the BHV-1 gE deletion mutant virion (BHV-1gEDelta3.1). Our findings suggest that the wild-type BHV-1, with a functional gE protein, uses a different pathway of signaling events than the BHV-1 gE deletion mutant in replication. Our results indicate that the tyrosine phosphorylation of the cytoplasmic tail of BHV-1 gE is an important post-translational modification of the functional protein. An application of this study may be the use of tyrosine kinase inhibitors in controlling the BHV-1 infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683338     DOI: 10.1006/viro.1999.0164

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

3.  Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions.

Authors:  X Ren; J S Harms; G A Splitter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Phosphorylation of Bovine Herpesvirus 1 VP8 Plays a Role in Viral DNA Encapsidation and Is Essential for Its Cytoplasmic Localization and Optimal Virion Incorporation.

Authors:  Kuan Zhang; Robert Brownlie; Marlene Snider; Sylvia van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene.

Authors:  Shaw M Akula; Paul Bolin; Paul P Cook
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

6.  COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism.

Authors:  Richard J Smeyne; Jeffrey B Eells; Debotri Chatterjee; Matthew Byrne; Shaw M Akula; Srinivas Sriramula; Dorcas P O'Rourke; Peter Schmidt
Journal:  Mov Disord       Date:  2022-06-09       Impact factor: 9.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.